| DAA1020 |
Heart disease (Male) |
Pathological |
heart |
Human |
— |
SeriesIncidence |
|
| DAA1021 |
Heart disease (Female) |
Pathological |
heart |
Human |
— |
SeriesIncidence |
|
| DAA1022 |
Coronary heart disease (Male) |
Pathological |
heart |
Human |
— |
SeriesIncidence |
|
| DAA1023 |
Coronary heart disease (Female) |
Pathological |
heart |
Human |
— |
SeriesIncidence |
|
| DAA1024 |
Heart attack (Male) |
Pathological |
heart |
Human |
— |
SeriesIncidence |
|
| DAA1025 |
Heart attack (Female) |
Pathological |
heart |
Human |
— |
SeriesIncidence |
|
| DAA1046 |
Hypertension (high BP or taking meds) (Male) |
Pathological |
artery |
Human |
— |
SeriesIncidence |
|
| DAA1047 |
Hypertension (high BP or taking meds) (Female) |
Pathological |
artery |
Human |
— |
SeriesIncidence |
|
| DAA1063 |
Orthostatic hypotension incidence increases |
Physiological |
cardiovascular system |
Human |
— |
— |
|
| DAA1292 |
NYN domain and retroviral integrase containing |
Molecular |
heart |
Mouse |
Nynrin |
8.0% Increase Gene Expression Level |
|
| DAA1293 |
eukaryotic translation initiation factor 2a |
Molecular |
heart |
Mouse |
Eif2a |
8.0% Decrease Gene Expression Level |
|
| DAA1294 |
fibronectin 1 |
Molecular |
heart |
Mouse |
Fn1 |
8.0% Increase Gene Expression Level |
|
| DAA1295 |
growth arrest and DNA-damage-inducible 45 alpha |
Molecular |
heart |
Mouse |
Gadd45a |
5.0% Decrease Gene Expression Level |
|
| DAA1296 |
RIKEN cDNA 6720462K09 gene |
Molecular |
heart |
Mouse |
6720462K09Rik |
5.0% Decrease Gene Expression Level |
|
| DAA1297 |
neural precursor cell expressed, developmentally down-regulated gene 8 |
Molecular |
heart |
Mouse |
Nedd8 |
3.0% Decrease Gene Expression Level |
|
| DAA1298 |
opsin 1 (cone pigments), long-wave-sensitive |
Molecular |
heart |
Mouse |
Opn1lw |
19.0% Increase Gene Expression Level |
|
| DAA1963 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase |
Molecular |
heart |
Mouse |
Alox5 |
— |
|
| DAA1965 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) mRNA expression increase |
Molecular |
heart |
Mouse |
Alox5 |
— |
|
| DAA1968 |
Dnmt3a mRNA expression decrease |
Molecular |
heart |
Mouse |
Dnmt3a |
— |
|
| DAA1969 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) mRNA expression decrease |
Molecular |
heart |
Mouse |
Alox5 |
— |
|
| DAA1985 |
Diastolic dysfunction with aging |
Physiological |
cardiovascular system |
Human |
— |
— |
|
| DAA1994 |
Increase in collagen in the arterial intima |
Physiological |
arterial intima |
Human |
— |
100.0% Increase Protein level |
|
| DAA1995 |
Decrease in collagen in the venous intima |
Physiological |
venous intima |
Human |
— |
42.0% Decrease Protein level |
|
| DAA2021 |
Diminution in the resting cardiac output |
Physiological |
heart |
Human |
— |
— |
|
| DAA2026 |
Mutations in mitochondrial DNA accumulate |
Physiological |
heart, kidney, skeletal muscle, cerebral cortex, cerebellum |
Human |
— |
— |
|